Additionally, their under-development triple agonist, Retatrutide, has shown unprecedented weight loss effects in phase 2 clinical trials.16 Matthias Tschp and his team discovered that dual agonists targeting both GLP-1 and GIP receptors (GIPR) are more effective in treating diabetes than those targeting only GLP-1R
One of the most visible effects is on the skin
Over time, these tendons can develop micro-tears, leading to chronic inflammation, weakness, and stiffness that limit daily function
NAC is a derivative of the amino acid cysteine and is primarily valued as a precursor to glutathione
Hao T, Du X, Yang S, Zhang Y, Liang F
Lors du suivi le plus long, 33,4 % des participants randomiss pour recevoir du smaglutide ont obtenu une perte de poids 20 %, contre 2,2 % pour le placebo (RR 15,08, IC 95 % 9,31 24,43)